Eclipse Life Sciences
NC - Research Triangle ParkBiotechnology
Focus: Eclipse Life Sciences is a biotechnology company headquartered in Research Triangle Park, NC, specializing in acquisitions and development of therapeutic programs.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Eclipse Life Sciences?
AI assessmentEclipse is a speculative early-stage play best suited for risk-tolerant professionals betting on acquisition synergy execution rather than those seeking established programs or job security.
Why Work Here
- Focused acquisition and development strategy in a growing biotech hub (Research Triangle Park)
- Early-stage pipeline with potential upside in ophthalmology (EC-104 in Phase 1/2 for Diabetic Macular Edema)
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
EC-104 high dose
Diabetic Macular EdemaClinical Trials (1)
NCT06536491EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
Phase 1/2Help build intelligence for Eclipse Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.